AU2001291225A1 - Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients - Google Patents
Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patientsInfo
- Publication number
- AU2001291225A1 AU2001291225A1 AU2001291225A AU9122501A AU2001291225A1 AU 2001291225 A1 AU2001291225 A1 AU 2001291225A1 AU 2001291225 A AU2001291225 A AU 2001291225A AU 9122501 A AU9122501 A AU 9122501A AU 2001291225 A1 AU2001291225 A1 AU 2001291225A1
- Authority
- AU
- Australia
- Prior art keywords
- hiv
- analysis
- infected patients
- clinical care
- coreceptor use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23567100P | 2000-09-26 | 2000-09-26 | |
US60/235,671 | 2000-09-26 | ||
US28235401P | 2001-04-06 | 2001-04-06 | |
US60/282,354 | 2001-04-06 | ||
PCT/US2001/029881 WO2002027321A2 (en) | 2000-09-26 | 2001-09-25 | Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001291225A1 true AU2001291225A1 (en) | 2002-04-08 |
Family
ID=26929120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001291225A Abandoned AU2001291225A1 (en) | 2000-09-26 | 2001-09-25 | Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients |
Country Status (4)
Country | Link |
---|---|
US (4) | US6727060B2 (de) |
EP (2) | EP1350100A2 (de) |
AU (1) | AU2001291225A1 (de) |
WO (1) | WO2002027321A2 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7344830B2 (en) * | 2000-09-26 | 2008-03-18 | Health Research Inc. | Heteroduplex tracking assay |
US7718356B2 (en) * | 2000-09-26 | 2010-05-18 | Health Research Inc. | Heteroduplex tracking assay |
US7203952B2 (en) * | 2001-03-27 | 2007-04-10 | Digeo, Inc. | Passive program completion status indicator for an electronic program guide |
FR2875410B1 (fr) * | 2004-09-23 | 2012-11-16 | Guerbet Sa | Composes de diagnostique pour le ciblage de recpteur a chimiokines |
US7248359B2 (en) * | 2005-03-30 | 2007-07-24 | Applera Corporation | Combining multi-spectral light from spatially separated sources |
CA2658227A1 (en) * | 2006-01-17 | 2007-07-26 | Health Research, Inc. | Heteroduplex tracking assay |
AU2007211495B2 (en) * | 2006-02-03 | 2012-11-15 | Virco Bvba | Quantitative HIV phenotype or tropism assay |
EP1914309A1 (de) * | 2006-10-20 | 2008-04-23 | Eurofins Viralliance Inc. | Verfahren zur Ermittlung des HIV-1 Tropismus für CCR5 und/oder CXCR4 Co-Rezeptoren und/oder deren Empfindlichkeit gegenüber Eingangs-Inhibitoren |
WO2008047227A2 (en) * | 2006-10-20 | 2008-04-24 | Eurofins Viralliance Inc. | Method of assaying hiv-1 tropism for ccr5 and/or cxcr4 co-receptor and/or susceptibility to entry inhibitors |
NZ585002A (en) | 2007-10-26 | 2012-06-29 | Alfred Health | Diagnostic and therapeutic protocols for hiv |
WO2009100284A2 (en) * | 2008-02-06 | 2009-08-13 | University Of Massachusetts | Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
US7888034B2 (en) * | 2008-07-01 | 2011-02-15 | 454 Life Sciences Corporation | System and method for detection of HIV tropism variants |
WO2010028014A1 (en) | 2008-09-03 | 2010-03-11 | Abbott Laboratories | Assays and kits for determining hiv-1 tropism |
US8695420B1 (en) | 2010-06-30 | 2014-04-15 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Liquid level sensing system |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5766598A (en) | 1991-03-07 | 1998-06-16 | Virogenetics Corporation | Recombinant attenuated ALVAC canarypoxvirus expression vectors containing heterologous DNA segments encoding lentiviral gene products |
US5863542A (en) | 1991-03-07 | 1999-01-26 | Virogenetics Corporation | Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
DE69233087T2 (de) | 1991-11-22 | 2003-12-24 | Affymetrix Inc N D Ges D Staat | Verfahren zur Herstellung von Polymerarrays |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US6045996A (en) | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
US5631734A (en) | 1994-02-10 | 1997-05-20 | Affymetrix, Inc. | Method and apparatus for detection of fluorescently labeled materials |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US6033850A (en) | 1994-03-15 | 2000-03-07 | Affymetrix, Inc. | Electrochemical denaturation of double-stranded nucleic acid |
US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5710000A (en) | 1994-09-16 | 1998-01-20 | Affymetrix, Inc. | Capturing sequences adjacent to Type-IIs restriction sites for genomic library mapping |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
US5639858A (en) | 1995-03-22 | 1997-06-17 | Tularik, Inc. | Human signal transducer and binding assays |
US5624711A (en) | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US5968740A (en) | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
US5733729A (en) | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
US5843655A (en) | 1995-09-18 | 1998-12-01 | Affymetrix, Inc. | Methods for testing oligonucleotide arrays |
US6022963A (en) | 1995-12-15 | 2000-02-08 | Affymetrix, Inc. | Synthesis of oligonucleotide arrays using photocleavable protecting groups |
US5837464A (en) * | 1996-01-29 | 1998-11-17 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
US6013440A (en) | 1996-03-11 | 2000-01-11 | Affymetrix, Inc. | Nucleic acid affinity columns |
US6107019A (en) | 1996-06-14 | 2000-08-22 | Progenics Pharmaceuticals, Inc. | Method for preventing HIV-1 infection of CD4+ cells |
US5851759A (en) * | 1996-04-19 | 1998-12-22 | Chiron Corporation | Heteroduplex tracking assay (HTA) for genotyping HCV |
US5994515A (en) | 1996-06-25 | 1999-11-30 | Trustees Of The University Of Pennsylvania | Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
US6461809B1 (en) * | 1996-10-15 | 2002-10-08 | Bio-Tech Imaging, Inc | Methods of improving infectivity of cells for viruses |
US5990091A (en) | 1997-03-12 | 1999-11-23 | Virogenetics Corporation | Vectors having enhanced expression, and methods of making and uses thereof |
US6004777A (en) | 1997-03-12 | 1999-12-21 | Virogenetics Corporation | Vectors having enhanced expression, and methods of making and uses thereof |
US5843721A (en) | 1997-07-03 | 1998-12-01 | Tularik Inc. | Nucleic acids encoding human NIK protein |
AU9495098A (en) | 1997-09-19 | 1999-04-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods for use of interleukin 4 (il-4) to treat human immunodeficiency virus infection |
EP1027456B1 (de) | 1997-10-31 | 2005-03-16 | Affymetrix, Inc. (a Delaware Corporation) | Expressionsprofile in adulten und fötalen organen |
EP1088108A4 (de) | 1998-06-23 | 2002-04-17 | Uab Research Foundation | Auf zellen basierender nachweis zur infektiösität und sensibilität des immunschwäche virus |
DE60123781T2 (de) * | 2000-04-27 | 2007-08-16 | Consejo Superior de Investigaciónes Científicas | Methode zum nachweis von minderheitsgenomen in viralen quasi-spezies unter verwendung von dna-mikrochips |
US20040067498A1 (en) * | 2000-04-28 | 2004-04-08 | Ahmed Chenna | Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
US7718356B2 (en) * | 2000-09-26 | 2010-05-18 | Health Research Inc. | Heteroduplex tracking assay |
US20040110125A1 (en) * | 2001-06-04 | 2004-06-10 | Petropoulos Christos J. | Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays |
US7247439B1 (en) * | 2001-06-04 | 2007-07-24 | Monogram Biosciences, Inc. | Method of evaluating a patient antibody response to envelope proteins of a virus |
US7097970B2 (en) * | 2001-06-04 | 2006-08-29 | Monogram Biosciences, Inc. | Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs |
TR200402517T1 (tr) | 2002-03-29 | 2007-12-24 | Innogenetics N.V. | HBV ilaç direnci tespit metotları |
-
2001
- 2001-09-25 WO PCT/US2001/029881 patent/WO2002027321A2/en active Application Filing
- 2001-09-25 AU AU2001291225A patent/AU2001291225A1/en not_active Abandoned
- 2001-09-25 US US09/963,064 patent/US6727060B2/en not_active Expired - Lifetime
- 2001-09-25 EP EP01971329A patent/EP1350100A2/de not_active Withdrawn
- 2001-09-25 EP EP10012774.5A patent/EP2333543B1/de not_active Expired - Lifetime
-
2003
- 2003-10-29 US US10/695,846 patent/US7294458B2/en not_active Expired - Lifetime
-
2007
- 2007-10-16 US US11/872,842 patent/US7943297B2/en not_active Expired - Fee Related
-
2008
- 2008-01-11 US US12/013,309 patent/US20090035749A2/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7943297B2 (en) | 2011-05-17 |
US6727060B2 (en) | 2004-04-27 |
US20090117548A2 (en) | 2009-05-07 |
WO2002027321A9 (en) | 2003-09-18 |
US20040121318A1 (en) | 2004-06-24 |
US20080096209A1 (en) | 2008-04-24 |
WO2002027321A2 (en) | 2002-04-04 |
WO2002027321A3 (en) | 2003-08-07 |
EP2333543B1 (de) | 2018-01-10 |
US7294458B2 (en) | 2007-11-13 |
EP2333543A1 (de) | 2011-06-15 |
EP1350100A2 (de) | 2003-10-08 |
US20020197734A1 (en) | 2002-12-26 |
US20080227084A1 (en) | 2008-09-18 |
US20090035749A2 (en) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002232104A1 (en) | Syringe for use in blood analysis | |
AU2001291225A1 (en) | Analysis of hiv-1 coreceptor use in the clinical care of hiv-1-infected patients | |
DE50002860D1 (de) | Spreizbares medizinisches instrument, insbesondere laryngoskop | |
ATE216875T1 (de) | Nichtinvasive impfung durch die haut | |
AU2001296550A1 (en) | Dermabrasion and skin care apparatus | |
AU2001229778A1 (en) | Health care payment and compliance system | |
MA26050A1 (fr) | Infusion de liquides dans le corps humain ou animal | |
GB9904585D0 (en) | Clinical and diagnostic database | |
AR028426A1 (es) | Una composicion farmaceutica y procedimiento de tratamiento de enfermedades de disfunsion cognitiva en un mamifero | |
AU2001246377A1 (en) | Positioning aid for use in performing a tomographic functional examination of the cervical spine | |
EP1395823A4 (de) | In blutanalysegeräten verwendeter einwegbecher und -konus | |
AU2001275492A1 (en) | Illuminating dental/medical examination mirror | |
PT1230230E (pt) | Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico | |
AU2002233357A1 (en) | Determining the risk of caries in a patient | |
ATE258035T1 (de) | Wegwerfartikel für menschliche fäkalien | |
FI20000818A0 (fi) | Dermatologinen käyttö ja valmiste | |
ITMI20010737A0 (it) | Adesivo per protesi dentarie e procedimenti per la sua preparazione | |
DK1265577T3 (da) | Medicinsk eller dentalmedicinsk behandlingsstol | |
GB0019302D0 (en) | Biological materials and the use thereof for the treatment of disease | |
AU2001285683A1 (en) | Mild enrichment of foetal cells from peripheral blood and use thereof | |
IL162095A0 (en) | Formulations for use in medical or diagnostic procedures | |
IL150623A0 (en) | Measurement system for examining a section of tissue on a patient and the use of a measurement system of this type | |
AU2002220744A1 (en) | T-cell epitope of the papillomavirus L1 and E7 protein and use thereof in diagnostics and therapy | |
AU2003223033A1 (en) | System for point of care diagnosis and/or analysis | |
EP1424556A4 (de) | Blutuntersuchungsgerät |